Digital Pathology Market - Global Forecast 2026-2032

The Digital Pathology Market is projected to reach USD 1.66 Billion in 2026. It is expected to continue growing at a CAGR of 16.05%, reaching USD 4.09 Billion by 2032.

Digital pathology is reshaping anatomic pathology by converting glass-slide workflows into connected, image-based diagnostic ecosystems. The market centers on whole slide imaging, image management systems, laboratory information system integration, computational pathology, telepathology, and regulated artificial intelligence tools that support pathologists in high-volume clinical and research settings.

Adoption is being driven by sustained growth in oncology testing, expanding precision medicine programs, pathology workforce shortages, and the need for faster subspecialty consultation across distributed health systems. Regulatory milestones have also increased confidence: the U.S. Food and Drug Administration authorized the first whole slide imaging system for primary diagnosis in 2017, and the College of American Pathologists has published validation guidance for clinical whole slide imaging implementation.

For industry vendors, digital pathology is no longer a limited research or education tool. It is becoming an enterprise infrastructure layer for diagnostic quality, workload balancing, biomarker quantification, data-rich pathology archives, and AI-enabled clinical decision support.

Transformative Shifts in the Digital Pathology Landscape

The digital pathology landscape is shifting from scanner-led purchasing to enterprise workflow transformation. Hospitals, reference laboratories, academic medical centers, and pharmaceutical research organizations are evaluating platforms based on interoperability, diagnostic-grade image quality, uptime, cybersecurity, data governance, and integration with LIS, PACS, cloud, and laboratory automation systems.

A second major shift is the move from local deployment to hybrid and cloud-enabled architectures. High-resolution whole slide images generate large data volumes, making storage strategy, compression, retrieval speed, and vendor-neutral image access central to procurement decisions. DICOM-compatible pathology imaging and HL7-based connectivity are becoming increasingly important as pathology converges with radiology, genomics, and oncology informatics.

The competitive landscape is also evolving from hardware differentiation toward end-to-end value. Scanner throughput, z-stack capability, image fidelity, AI readiness, validation support, and global service coverage now influence purchasing decisions as much as device specifications.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of digital pathology by turning whole slide images into structured, searchable, and quantifiable diagnostic assets. Current AI use cases include tumor detection, tissue segmentation, mitotic counting, quality control, workload triage, and biomarker scoring support. In 2021, the U.S. Food and Drug Administration authorized an AI-based tool to help pathologists identify areas suspicious for cancer in prostate biopsy images, signaling the transition from research algorithms to regulated clinical support.

The cumulative impact of AI is strongest when algorithms are embedded into validated workflows rather than deployed as standalone tools. Pathologists remain accountable for diagnosis, while AI can reduce repetitive visual search, improve consistency in quantification, and help prioritize complex or time-sensitive cases.

Responsible adoption requires site-specific validation, human-in-the-loop oversight, dataset diversity, audit trails, cybersecurity controls, and continuous performance monitoring. As foundation models and multimodal pathology systems mature, the highest-value applications will combine image data with clinical, molecular, and treatment-response data.

Key Regional Insights

North America remains one of the most advanced regions for digital pathology adoption, supported by large integrated health systems, academic cancer centers, reference laboratories, established regulatory pathways, and strong investment in computational pathology. The United States leads in regulated clinical adoption, while Canada benefits from provincial telepathology initiatives and geographically distributed care models that support remote consultation across wide service areas.

Europe is progressing through national health digitization programs, cancer network modernization, and regulated in vitro diagnostic frameworks. The United Kingdom has established notable digital pathology deployments within public health-linked networks, while Germany, France, Italy, and Spain are increasing investment in hospital digitization and oncology diagnostics. European Union IVDR requirements are raising expectations for clinical evidence, traceability, and post-market surveillance.

Asia-Pacific is expanding rapidly because of high diagnostic volumes, rising cancer incidence, and strong digital health initiatives in China, Japan, South Korea, India, and Australia. Latin America is led by Brazil and Mexico, where private laboratory networks and urban specialty centers are early adopters. The Middle East, particularly GCC healthcare systems, is investing in smart hospitals and advanced oncology infrastructure, while Africa shows growing telepathology relevance in response to pathologist shortages, geographic access gaps, and the need for remote specialist review.

Key Group Insights

The European Union is shaping digital pathology through harmonized regulatory expectations, cross-border health data initiatives, and hospital digitization funding. EU-wide emphasis on interoperability, IVDR compliance, cybersecurity, and evidence-based procurement is pushing suppliers and healthcare systems to provide transparent validation data, lifecycle support, and traceable clinical performance documentation.

G7 markets are setting the pace for regulated adoption because they combine mature healthcare reimbursement structures, advanced oncology programs, high pathology informatics maturity, and strong academic research capacity. NATO countries show overlapping demand for secure health data infrastructure, resilient medical supply chains, and interoperable digital systems that can support civilian and military medical readiness.

BRICS economies represent a scale-driven opportunity, with China and India offering high-volume diagnostic demand, Brazil strengthening regional laboratory networks, Russia maintaining interest in domestic health technology capacity, and South Africa reinforcing the role of telepathology in specialist access. ASEAN adoption is uneven but promising, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines pursuing digital health modernization at different speeds. The GCC is one of the most active groups for premium healthcare infrastructure, led by Saudi Arabia, the United Arab Emirates, Qatar, and other states investing in oncology centers, smart hospitals, and AI-enabled care delivery.

Key Country Insights

The United States is the most influential digital pathology market because of FDA-authorized systems, large reference laboratories, academic medical centers, and strong investment in pathology AI. Canada is advancing through provincial care models and remote pathology consultation needs, while Mexico is growing through private diagnostics networks and medical tourism-linked specialty care. Brazil is the leading Latin American opportunity, supported by major urban laboratory groups and expanding oncology services.

In Europe, the United Kingdom is notable for public health-linked digital pathology networks and cancer pathway modernization. Germany combines high healthcare expenditure with strong medical technology infrastructure, while France is advancing hospital digitization and oncology diagnostics. Italy and Spain are adopting digital workflows through regional hospital systems and research hospitals, and Russia remains focused on domestic diagnostic capacity and large-scale public healthcare needs.

In Asia-Pacific, China offers scale, domestic scanner development, and hospital digitization momentum, while India has strong demand due to diagnostic volume and pathologist access gaps. Japan emphasizes quality, regulatory rigor, and advanced cancer care, while South Korea combines digital hospital infrastructure with strong medtech innovation. Australia is a mature adopter for telepathology and regional access, particularly where specialist pathology services must cover large geographic distances.

Actionable Recommendations for Industry Leaders

Industry vendors should treat digital pathology as an enterprise transformation program rather than a device purchase. The first priority is a validated roadmap that links scanner deployment, image management, LIS integration, storage architecture, cybersecurity, pathologist training, and clinical governance.

Technology providers should prioritize interoperable platforms, transparent performance data, regulatory readiness, and service models that support multi-site scaling. Healthcare providers should build business cases around turnaround time, subspecialty access, workload balancing, quality assurance, education, and research enablement rather than relying only on direct labor savings.

AI adoption should begin with high-value, narrow use cases such as quality control, triage, or biomarker quantification support, followed by phased expansion after validation. Companies should also establish data stewardship policies, algorithm monitoring, procurement standards, and cross-functional governance involving pathology, IT, compliance, oncology, and executive stakeholders.

Research Methodology

This executive summary reflects a structured secondary and primary research approach aligned with established market intelligence standards. Insights are derived from verified public sources, including regulatory databases, device authorizations, European regulatory frameworks, CAP guidance, peer-reviewed pathology literature, national digital health programs, product documentation, hospital digitization evidence, and clinical implementation studies.

The analysis triangulates demand indicators across clinical adoption, regulatory maturity, installed infrastructure, oncology testing needs, workforce constraints, technology readiness, and procurement behavior. Regional, group, and country insights are assessed through comparable variables such as healthcare expenditure, cancer diagnostics capacity, digital health policy, telemedicine infrastructure, and laboratory consolidation.

Claims are limited to evidence-backed observations and clearly established market patterns. The methodology avoids unsupported market sizing assumptions and emphasizes validated developments in whole slide imaging, AI-enabled pathology, interoperability, and clinical implementation.

Conclusion

Digital pathology is entering a scale-up phase as healthcare systems move from isolated pilots to enterprise imaging strategies. Whole slide imaging, AI-enabled workflow support, cloud-ready image management, and interoperable data infrastructure are becoming core elements of modern pathology operations.

The strongest market opportunities will emerge where technology improves diagnostic access, quality, speed, and consistency without disrupting pathologist accountability. Organizations that invest in validation, interoperability, governance, and change management will be better positioned to capture the clinical and operational value of digital pathology.

As AI and computational pathology mature, the field will increasingly connect tissue images with molecular, clinical, and treatment data. This convergence positions digital pathology as a foundational capability for precision medicine, oncology innovation, and the future of data-driven diagnostics.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Digital Pathology Market, by Type

7.1. Introduction
7.2. Human Pathology
7.3. Veterinary Pathology

8. Digital Pathology Market, by Product

8.1. Introduction
8.2. Hardware
8.2.1. Displays
8.2.1.1. Consumer off the Shelf
8.2.1.2. Medical Grade
8.2.1.3. Professional Grade
8.2.2. Scanners
8.2.2.1. Brightfield Scanners
8.2.2.2. Fluorescence Scanners
8.2.3. Storage Systems
8.3. Services
8.3.1. Consulting & Implementation Services
8.3.2. Maintenance & Support Services
8.3.3. Training Services
8.4. Software
8.4.1. Image Management Systems (IMS)
8.4.2. Laboratory Information Systems (LIS)
8.4.3. Picture Archiving and Communication Systems (PACS)

9. Digital Pathology Market, by Laboratory Throughput

9.1. Introduction
9.2. Low-Throughput
9.3. Medium-Throughput
9.4. High-Throughput

10. Digital Pathology Market, by Deployment Model

10.1. Introduction
10.2. On-Premises
10.3. Cloud-Based
10.4. Hybrid

11. Digital Pathology Market, by Application

11.1. Introduction
11.2. Biomarker Discovery
11.3. Disease Diagnosis
11.3.1. Infectious Diseases
11.3.2. Neurology
11.3.3. Oncology
11.4. Drug Discovery & Development
11.5. Telepathology
11.6. Toxicology Studies
11.7. Training & Education

12. Digital Pathology Market, by End User

12.1. Introduction
12.2. Academic & Research Institutes
12.3. Contract Research Organizations
12.4. Government & Regulatory Bodies
12.5. Hospitals & Diagnostic Labs
12.6. Pharmaceutical & Biotechnology Companies

13. Digital Pathology Market, by Region

13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Africa
13.5. Latin America
13.6. Middle East

14. Digital Pathology Market, by Group

14.1. NATO
14.2. G7
14.3. European Union
14.4. BRICS
14.5. ASEAN
14.6. GCC

15. Digital Pathology Market, by Country

15.1. United States
15.2. China
15.3. Germany
15.4. Japan
15.5. India
15.6. United Kingdom
15.7. France
15.8. Canada
15.9. Australia
15.10. Italy
15.11. South Korea
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain

16. Competitive Landscape

16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025

17. Company Profiles

17.1. 3DHISTECH Ltd.
17.2. Aiforia Technologies PLC
17.3. Aignostics GmbH
17.4. Akoya Biosciences
17.5. Charles River Laboratories
17.6. Corista LLC
17.7. Danaher Corporation
17.8. Deep Bio Inc.
17.9. Epredia
17.10. F. Hoffmann-La Roche Ltd.
17.11. FUJIFILM Holdings Corporation
17.12. General Electric Company
17.13. Gestalt Diagnostics Ltd.
17.14. Hamamatsu Photonics K.K.
17.15. Huron Digital Pathology
17.16. Ibex Medical Analytics Ltd.
17.17. Indica Labs
17.18. Koninklijke Philips N.V.
17.19. Laboratory Corporation of America Holdings
17.20. Mikroscan Technologies, Inc.
17.21. Mindpeak GmbH
17.22. Motic
17.23. Nikon Corporation
17.24. Olympus Corporation
17.25. OptraSCAN Inc.
17.26. Owkin, Inc.
17.27. Pathcore Inc.
17.28. PathPresenter Corporation
17.29. PerkinElmer, Inc.
17.30. Proscia, Inc.
17.31. Qritive Inc.
17.32. Quest Diagnostics Incorporated
17.33. Sectra AB
17.34. Visiopharm A/S
17.35. Xybion Digital Inc.

List of Figures

FIGURE 1. GLOBAL DIGITAL PATHOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DIGITAL PATHOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

List of Tables

TABLE 1. GLOBAL DIGITAL PATHOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL HUMAN PATHOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL VETERINARY PATHOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DISPLAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DISPLAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL DISPLAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CONSUMER OFF THE SHELF MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MEDICAL GRADE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MEDICAL GRADE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MEDICAL GRADE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PROFESSIONAL GRADE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SCANNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SCANNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SCANNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL BRIGHTFIELD SCANNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL FLUORESCENCE SCANNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CONSULTING & IMPLEMENTATION SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL TRAINING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TRAINING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TRAINING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL IMAGE MANAGEMENT SYSTEMS (IMS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL LABORATORY INFORMATION SYSTEMS (LIS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL LOW-THROUGHPUT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MEDIUM-THROUGHPUT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HIGH-THROUGHPUT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ON-PREMISES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ON-PREMISES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ON-PREMISES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL HYBRID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL BIOMARKER DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DISEASE DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL TELEPATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL TELEPATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL TELEPATHOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL TOXICOLOGY STUDIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL TRAINING & EDUCATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL GOVERNMENT & REGULATORY BODIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 142. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 143. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 144. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 145. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 146. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 147. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 148. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 149. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 150. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 151. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 152. EUROPE DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 168. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 169. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 170. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 171. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 172. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 173. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 174. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 175. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 176. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 177. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 178. AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. NATO DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. NATO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 208. NATO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 209. NATO DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 210. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 211. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 212. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 213. NATO DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 214. NATO DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 215. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 216. NATO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. NATO DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 218. NATO DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 219. G7 DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 220. G7 DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 221. G7 DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 222. G7 DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 223. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 224. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 225. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 226. G7 DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 227. G7 DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 228. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 229. G7 DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. G7 DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 231. G7 DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 247. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 248. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 249. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 250. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 251. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 252. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 253. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 254. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 255. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 257. BRICS DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 258. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 260. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 261. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 262. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 263. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 264. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 265. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 266. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 267. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 268. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 270. ASEAN DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. GCC DIGITAL PATHOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 272. GCC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 273. GCC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 274. GCC DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 275. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 276. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 277. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 278. GCC DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 279. GCC DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 280. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 281. GCC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 282. GCC DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 283. GCC DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. CHINA DIGITAL PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 299. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 300. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 301. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 302. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 303. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 304. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 305. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 306. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 307. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 308. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 310. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. GERMANY DIGITAL PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 313. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 314. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 315. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 316. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 317. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 318. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 319. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 320. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 321. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 323. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 324. JAPAN DIGITAL PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 326. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 327. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 328. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 329. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 330. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 331. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 332. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 333. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 334. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 335. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 336. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 337. INDIA DIGITAL PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 338. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 339. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 340. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 341. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 342. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 343. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 344. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 345. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 346. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 347. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 348. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 349. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 350. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 351. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 352. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 353. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 354. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 355. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 356. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 357. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 358. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 359. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MODEL, 2017-2032 (USD MILLION)
TABLE 360. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 361. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, 2017-2032 (USD MILLION)
TABLE 362. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 363. FRANCE DIGITAL PATHOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 364. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 365. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 366. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 367. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY DISPLAYS, 2017-2032 (USD MILLION)
TABLE 368. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, 2017-2032 (USD MILLION)
TABLE 369. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 370. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 371. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY LABORATORY THROUGHPUT, 2017-2032 (USD MILLION)
TABLE 372. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY DEPLOYMENT MO

Companies Mentioned

3DHISTECH Ltd.
Aiforia Technologies PLC
Aignostics GmbH
Akoya Biosciences
Charles River Laboratories
Corista LLC
Danaher Corporation
Deep Bio Inc.
Epredia
F. Hoffmann-La Roche Ltd.
FUJIFILM Holdings Corporation
General Electric Company
Gestalt Diagnostics Ltd.
Hamamatsu Photonics K.K.
Huron Digital Pathology
Ibex Medical Analytics Ltd.
Indica Labs
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
Mikroscan Technologies, Inc.
Mindpeak GmbH
Motic
Nikon Corporation
Olympus Corporation
OptraSCAN Inc.
Owkin, Inc.
Pathcore Inc.
PathPresenter Corporation
PerkinElmer, Inc.
Proscia, Inc.
Qritive Inc.
Quest Diagnostics Incorporated
Sectra AB
Visiopharm A/S
Xybion Digital Inc.

Table Information

Report Attribute	Details
No. of Pages	193
Published	August 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.66 Billion
Forecasted Market Value ( USD ) by 2032	$ 4.09 Billion
Compound Annual Growth Rate	16.0%
Regions Covered	Global
No. of Companies Mentioned	35

License	Format	Properties	Price
1 - 5 USER LICENSE PDF, Excel and Online Access		This is a 1-5 user license, allowing up to five users have access to the product.	€3184EUR$3,545USD£2,720GBP €3538EUR$3,939USD£3,022GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€4817EUR$5,363USD£4,115GBP €5352EUR$5,959USD£4,572GBP

Transformative Shifts in the Digital Pathology Landscape

Cumulative Impact of Artificial Intelligence

Key Regional Insights

Key Group Insights

Key Country Insights

Actionable Recommendations for Industry Leaders

Research Methodology

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Comprehensive Digital Pathology Scanner Market - Global Forecast 2026-2032

Digital Pathology Slide Scanner Market - Global Forecast 2026-2032

Digital Pathology Market by Product, Application, Indication, End User Al- Global Forecast to 2031

Digital Pathology Market Size, Share, Trends and Forecast by Product, Type, Delivery Model, End-User, Application, and Region, 2026-2034

Digital Pathology Market Size, Share & Trends Analysis Report by Application (Academic Research, Disease Diagnosis), Product (Software, Device), End Use (Diagnostic Labs, Hospitals) with Growth Forecasts, 2026-2033